# Fluoxetine as a Quit Smoking AID for Depression Prone

> **NCT00113737** · NA · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Heart Diseases

## Interventions

- **DRUG:** fluoxetine
- **BEHAVIORAL:** cognitive behavioral therapy

## Key facts

- **NCT ID:** NCT00113737
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-02
- **Primary completion:** —
- **Final completion:** 2002-01
- **Target enrollment:** — (—)
- **Last updated:** 2016-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113737, "Fluoxetine as a Quit Smoking AID for Depression Prone". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00113737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*